Loader

Pathways

PathWhiz ID Pathway Meta Data

PW144397

Pw144397 View Pathway
drug action

Ropinirole Drug Metabolism Action Pathway

Homo sapiens

PW128056

Pw128056 View Pathway
drug action

Ropinirole Mechanism of Action Action Pathway

Homo sapiens
Ropinirole is a nonergoline dopamine agonist. used in the management in early and late Parkinson's disease. Ropinirole has a high affinity for and stimulates the post-synaptic dopamine receptors D2 in the central and peripheral nervous systems. The dopamine receptors (D2) are g-protein-coupled inhibitory neurons predominantly in the striatonigral, mesolimbic, and tuberoinfundibular systems. They inhibit adenylyl cyclase and calcium (Ca2+) channels and activate potassium channels leading to their physiological functions. The exact mechanism of action of ropinirole as a treatment for Parkinson’s disease is unknown, however, it is believed to be related to its ability to selectively stimulate dopamine D2 receptors within the caudate-putamen system in the brain. This system affects body movement. Negligible affinity is seen for ropinirole at α2 adrenoreceptors in the periphery and 5HT-1 receptor. Ropinirole has no affinity at the D1-like receptors, benzodiazepine or GABA receptors

PW126560

Pw126560 View Pathway
drug action

Ropivacaine

Homo sapiens
Ropivacaine an aminoamide analgesic is a racemic mixture of "S" and "R" enantiomers used for local anesthesia or for short term management of pain. Ropivacaine acts to block generation and propagation of action potentials by increasing the threshold for electrical excitation. This is done by blocking the sodium channel which causes a inhibits depolarization and decreases action potentials. Ropivacaine is metabolized in the liver by cytochrome P4501A through aromatic hydroxylation. The resulting metabolite 3-hydroxy ropivacaine is excreted by diruesis. Precaution should be taken with high systemic doses of ropivacaine which can effect the central nervous system and cardiovascular system.

PW000410

Pw000410 View Pathway
drug action

Ropivacaine Action Pathway

Homo sapiens
Ropivacaine exerts its local anaesthetic effect by blocking voltage-gated sodium channels in peripheral neurons. Ropivacaine diffuses across the neuronal plasma membrane in its uncharged base form. Once inside the cytoplasm, it is protonated and this protonated form enters and blocks the pore of the voltage-gated sodium channel from the cytoplasmic side. For this to happen, the sodium channel must first become active so that so that gating mechanism is in the open state. Therefore ropivacaine preferentially inhibits neurons that are actively firing.

PW144424

Pw144424 View Pathway
drug action

Ropivacaine Drug Metabolism Action Pathway

Homo sapiens

PW132534

Pw132534 View Pathway
metabolic

Rose bengal Drug Metabolism

Homo sapiens
Rose bengal is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Rose bengal passes through the liver and is then excreted from the body mainly through the kidney.

PW146286

Pw146286 View Pathway
drug action

Rose bengal Drug Metabolism Action Pathway

Homo sapiens

PW132558

Pw132558 View Pathway
metabolic

Rose bengal I-131 Drug Metabolism

Homo sapiens
Rose bengal I-131 is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Rose bengal I-131 passes through the liver and is then excreted from the body mainly through the kidney.

PW146131

Pw146131 View Pathway
drug action

Rose bengal I-131 Drug Metabolism Action Pathway

Homo sapiens

PW144537

Pw144537 View Pathway
drug action

Rosiglitazone Drug Metabolism Action Pathway

Homo sapiens